2010;56:1683 92. 542. Gurbel PA, Ohman EM, Jeong YH, et al. Toward a therapeutic window for antiplatelet therapy in the elderly. Eur Heart J. 2012;33:1187 9. 543. Schulman S, Beyth RJ, Kearon C, et al. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:257S 98S. 544. Lopes RD, Subherwal S, Holmes DN, et al. The association of in-hos- pital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarc- tion. Eur Heart J. 2012;33:2044 53. 545. Fox KA, Bassand JP, Mehta SR, et al. Influence of renal function on the effi- cacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes. Ann Intern Med. 2007; 147:304 10. 546. Spencer FA, Moscucci M, Granger CB, et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocar- dial infarction? Circulation. 2007;116:2793 801. 547. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123:2736 47. 548. Alexander KP, Roe MT, Chen AY, et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol. 2005;46:1479 87. 549. Boersma E, Harrington RA, Moliterno DJ, et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet. 2002;359:189 98. 550. Lincoff AM, Kleiman NS, Kereiakes DJ, et al. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and plannedglycoproteinIIb/IIIablockadeduringpercutaneouscoronaryrevas- cularization: REPLACE-2 randomized trial. JAMA. 2004;292:696 703. 551. Lamberts M, Olesen JB, Ruwald MH, et al. 